Seyed MohamadMehdi Moshtaghion | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Seyed MohamadMehdi Moshtaghion | Clinical Neuroscience | Research Excellence Award

Dr. Seyed MohamadMehdi Moshtaghion | Cabimer | Spain

Seyed MohamadMehdi Moshtaghion, MD, MSc, is a physician-scientist and Senior Research Technologist specializing in advanced therapies and diagnostic biomarkers for retinal degenerative diseases, with a primary focus on retinitis pigmentosa and age-related macular degeneration. His research integrates molecular biology, stem cell–based strategies, gene therapy, and artificial intelligence–driven retinal imaging to advance early diagnosis and personalized treatment approaches for vision-threatening disorders. He holds a medical degree from Shahid Beheshti University and advanced postgraduate training in biomedical investigation and molecular biology and biomedicine from the University of Seville, along with certification in animal experimentation. Dr. Moshtaghion has conducted research at leading international institutions, including Massachusetts Eye and Ear at Harvard Medical School, Karolinska Institutet, and CABIMER, contributing to translational projects that bridge laboratory discoveries with clinical ophthalmology. He has authored over 20 peer-reviewed scientific publications, with a total of 183 citations, an h-index of 8, and an i10-index of 8, reflecting consistent scholarly impact in the fields of retinal biology and regenerative medicine. His work has been presented at major international conferences such as ARVO and EURETINA, highlighting innovative therapeutic strategies and biomarker discovery in retinal disease research.

Citation Metrics (Google Scholar)

400
300
200
100
0

Citations
183

Documents
20

h-index
8

Citations

Documents

h-index


View Google Scholar Profile

Featured Publications

Interpretable deep learning for diagnosis of fungal and acanthamoeba keratitis using in vivo confocal microscopy images
– M Essalat, M Abolhosseini, TH Le, SM Moshtaghion, MR Kanavi, Scientific Reports, 13(1): 8953, 2023

Penetrating keratoplasty versus deep anterior lamellar keratoplasty in children and adolescents with keratoconus
– S Feizi, MA Javadi, F Karimian, M Abolhosseini, SM Moshtaghion, American Journal of Ophthalmology, 226: 13–21, 2021

Impression cytology for detection of clinically suspected ocular surface disorders: a cross-sectional study
– SM Moshtaghion, M Abolhosseini, MR Kanavi, SB Hosseini, European Journal of Ophthalmology, 31(3): 943–950, 2021

Outcomes of big-bubble deep anterior lamellar keratoplasty for pediatric keratoconus
– S Feizi, MA Javadi, M Najafi, M Abolhosseini, SM Moshtaghion, International Ophthalmology, 40(5): 1253–1259, 2020

Hendry Ramly | Clinical Neuroscience | Research Excellence Award

Published on by Neuroscientists

Dr. Hendry Ramly | Clinical Neuroscience | Research Excellence Award

Fiona Stanley | Australia

Dr. Hendry Ramly is a clinician–researcher with advanced training in general medicine, cardiology, and intensive care medicine, and a focused academic interest in non-traumatic out-of-hospital cardiac arrest and post-resuscitation care. His research is directly informed by frontline clinical practice across acute medicine, ICU, and cardiology, where he manages critically ill patients following cardiac arrest. Dr. Ramly’s primary research examines cardiovascular management strategies after return of spontaneous circulation, with particular emphasis on haemodynamic stabilisation, coronary pathology, and the timing and utility of urgent coronary angiography. Neurological outcomes are included as standard clinical endpoints, while the central focus remains on cardiovascular determinants of survival and in-hospital mortality. He is lead author of a retrospective observational cohort study published in Heart, Lung and Circulation (2025), evaluating outcomes of non-traumatic out-of-hospital cardiac arrest at a tertiary centre. His additional audit work includes thoracic surgical outcomes, geriatric referral pathways, and procedural adequacy in respiratory medicine. Through clinically driven research and multidisciplinary collaboration, Dr. Ramly aims to refine evidence-based pathways that improve survival, decision-making, and quality of care for patients following cardiac arrest.


View ORCID Profile

Featured Publication

Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Seyyed Ali Zendehbad | Clinical Neuroscience | Best Researcher Award

Dr. Seyyed Ali | Zendehbad University of Mazandaran | Iran

Dr. Seyyed Ali Zendehbad is a multidisciplinary researcher specializing in biomedical signal processing, cognitive computational neuroscience, and neurorehabilitation technologies. His research integrates deep learning, pattern recognition, and multimodal biological data modeling to enhance fatigue detection and neurorehabilitation systems. He has authored several peer-reviewed papers in reputable journals such as Scientific Reports, IEEE Access, Sensing and Bio-Sensing Research, and Healthcare Technology Letters, focusing on hybrid AI frameworks, EMG signal processing, and muscle synergy-based biofeedback mechanisms. Dr. Zendehbad’s work on developing intelligent rehabilitation systems, including his models like TraxVBF and FatigueNet, contributes to advancing telemonitoring and assistive technologies for neurological recovery. His scholarly output includes more than 25 documents, over 600 citations, and an h-index of 12, reflecting his growing impact in computational neuroscience and biomedical engineering. Recognized for innovation, he has achieved first-place awards in multiple national startup competitions and was honored with the Best Poster Award at the Congress of Neurology and Clinical Electrophysiology of Iran. As a postdoctoral researcher at the University of Mazandaran, his ongoing work emphasizes integrating trustworthy AI into telehealth systems, promoting equitable and efficient digital healthcare delivery through interdisciplinary research and technological innovation.

Profile: Orcid

Featured Publications

1. Mazrooei Rad, E., Mazinani, S. M., & Zendehbad, S. A. (2025). Diagnosis of Alzheimer’s disease using non-linear features of ERP signals through a hybrid attention-based CNN-LSTM model. Computer Methods and Programs in Biomedicine Update, 5, 100192.

2. Zendehbad, S. A., Sharifi Razavi, A., Tabrizi, N., & Sedaghat, Z. (2025). A systematic review of artificial intelligence techniques based on electroencephalography analysis in the diagnosis of epilepsy disorders: A clinical perspective. Epilepsy Research, 207, 107582.

3. Mazrooei Rad, E., Zendehbad, S. A., & Hosseinzadeh, V. (2025). Fetal QRS complex detection based on adaptive filters and peak detection. Research on Biomedical Engineering, 41(3), 424–438.

4. Zendehbad, S. A., Ghasemi, J., & Samsami Khodadad, F. (2025). FatigueNet: A hybrid graph neural network and transformer framework for real-time multimodal fatigue detection. Scientific Reports, 15(1), 640.

5. Safdel, A., Zendehbad, S. A., & Ghasemi, J. (2025). Advanced deep learning approaches for accurate and efficient suspicious behavior detection in surveillance videos. Computational Sciences and Engineering, 21(2), 1099.

Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Tatsuya Yamasoba | Clinical Neuroscience | Best Researcher Award

Prof. Tatsuya Yamasoba | University of Tokyo | Japan

Dr. Tatsuya Yamasoba is a Professor Emeritus at the University of Tokyo and Director of Tokyo Teishin Hospital, recognized internationally for his contributions to otology, neurotology, laryngology, and clinical neuroscience. He has published over 500 scientific papers in leading journals such as Science, Nature Chemistry, Nature Nanotechnology, Neuron, PNAS, and Neurology. His research focuses on regenerative medicine for sensorineural hearing loss, vestibular dysfunction, and dysphagia management in neurodegenerative diseases. With a citation index of over 24,150, an h-index of 75, and an i10-index of 353, his work has significantly advanced understanding and treatment of auditory and balance disorders. He has developed surgical techniques for severe hearing loss, pioneered galvanic vestibular stimulation therapy for disequilibrium, and improved aspiration prevention surgeries. Dr. Yamasoba has served as Editor-in-Chief of Auris Nasus Larynx and Associate Editor for ORL Journal and npj Aging and Mechanisms of Disease. He collaborates with leading research institutions including the University of Michigan and the University of California, Davis. His professional memberships include the International Federation of ORL Societies and the Asia Oceania Otorhinolaryngology and Head and Neck Society, reflecting his leadership and influence in advancing otolaryngology and auditory neuroscience globally.

Profile: Google Scholar

Featured Publications

Kujoth, G. C., Hiona, A., Pugh, T. D., Someya, S., Panzer, K., Wohlgemuth, S. E., et al. (2005). Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science, 309(5733), 481–484.

Tokunaga, T., Sakashita, M., Haruna, T., Asaka, D., Takeno, S., Ikeda, H., et al. (2015). Novel scoring system and algorithm for classifying chronic rhinosinusitis: The JESREC study. Allergy, 70(8), 995–1003.

Yamasoba, T., Lin, F. R., Someya, S., Kashio, A., Sakamoto, T., & Kondo, K. (2013). Current concepts in age-related hearing loss: Epidemiology and mechanistic pathways. Hearing Research, 303, 30–38.

Le Prell, C. G., Yamashita, D., Minami, S. B., Yamasoba, T., & Miller, J. M. (2007). Mechanisms of noise-induced hearing loss indicate multiple methods of prevention. Hearing Research, 226(1–2), 22–43.

Umezawa, K., Yoshida, M., Kamiya, M., Yamasoba, T., & Urano, Y. (2017). Rational design of reversible fluorescent probes for live-cell imaging and quantification of fast glutathione dynamics. Nature Chemistry, 9(3), 279–286.

Matsumoto, Y., Nichols, J. W., Toh, K., Nomoto, T., Cabral, H., Miura, Y., et al. (2016). Vascular bursts enhance permeability of tumour blood vessels and improve nanoparticle delivery. Nature Nanotechnology, 11(6), 533–538.

Iwasaki, S., & Yamasoba, T. (2014). Dizziness and imbalance in the elderly: Age-related decline in the vestibular system. Aging and Disease, 6(1), 38–47.

Someya, S., Xu, J., Kondo, K., Ding, D., Salvi, R. J., Yamasoba, T., Rabinovitch, P. S., et al. (2009). Age-related hearing loss in C57BL/6J mice is mediated by Bak-dependent mitochondrial apoptosis. Proceedings of the National Academy of Sciences, 106(46), 19432–19437.

Jane Paulsen | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof. Dr. Jane Paulsen | Clinical Neuroscience | Best Researcher Award

Prof. Dr. Jane Paulsen | University of Wisconsin Madison | United States

Dr. Jane S. Paulsen, Ph.D., is a Professor of Neurology and Vice Chair for Research at the University of Wisconsin–Madison, where she also contributes to the Department of Neurosciences Graduate Program. Her expertise lies in cognitive, psychiatric, and imaging correlates of neuropsychiatric disorders, with a strong focus on the early detection of brain diseases and the development of innovative methods for clinical trials. She has significantly advanced the understanding of genetic discrimination and the discovery and validation of biological and clinical markers of brain disease, incorporating neuroimaging and omics-based outcomes into her research. Dr. Paulsen completed her Ph.D. in Counseling Psychology at the University of Iowa, followed by postdoctoral training in Neuropsychology at the University of California, San Diego, where she worked on Alzheimer’s and geriatric psychiatry research. Over her career, she has held key positions including Director of the Huntington’s Disease Clinical Research Program at UCSD and has contributed extensively to advancing neuropsychological research and clinical applications. Her scholarly impact includes 4 published documents, 78 citations from 77 documents, and an h-index of 3, reflecting her influence in the fields of neurology, neuropsychology, and cognitive neuroscience.

Profiles: Scopus | Google Scholar | Reserach Gate | linked In

Featured Publications

Sachdev, P. S., Blacker, D., Blazer, D. G., Ganguli, M., Jeste, D. V., Paulsen, J. S., & Petersen, R. C. (2014). Classifying neurocognitive disorders: The DSM-5 approach. Nature Reviews Neurology, 10(11), 634–642.

Ross, C. A., Aylward, E. H., Wild, E. J., Langbehn, D. R., Long, J. D., Warner, J. H., & Paulsen, J. S. (2014). Huntington disease: Natural history, biomarkers and prospects for therapeutics. Nature Reviews Neurology, 10(4), 204–216.

Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M., & Shoulson, I. (2008). Detection of Huntington’s disease decades before diagnosis: The Predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry, 79(8), 874–880.

Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., Hayden, M. R., & International Huntington’s Disease Collaborative Group. (2004). A new model for prediction of the age of onset and penetrance for Huntington’s disease based on CAG length. Clinical Genetics, 65(4), 267–277.

Levy, M. L., Cummings, J. L., Fairbanks, L. A., Masterman, D., Miller, B. L., Craig, A. H., & Paulsen, J. S. (1998). Apathy is not depression. The Journal of Neuropsychiatry and Clinical Neurosciences, 10(3), 314–319.

Sachdev, P., Kalaria, R., O’Brien, J., Skoog, I., Alladi, S., Black, S. E., Blacker, D., & Paulsen, J. S. (2014). Diagnostic criteria for vascular cognitive disorders: A VASCOG statement. Alzheimer Disease & Associated Disorders, 28(3), 206–218.

Palmer, B. W., Heaton, R. K., Paulsen, J. S., Kuck, J., Braff, D., Harris, M. J., & Zisook, S. (1997). Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology, 11(3), 437–446.

Plis, S. M., Hjelm, D. R., Salakhutdinov, R., Allen, E. A., Bockholt, H. J., Long, J. D., & Calhoun, V. D. (2014). Deep learning for neuroimaging: A validation study. Frontiers in Neuroscience, 8, 229.

Mohamed, S., Paulsen, J. S., O’Leary, D., Arndt, S., & Andreasen, N. (1999). Generalized cognitive deficits in schizophrenia: A study of first-episode patients. Archives of General Psychiatry, 56(8), 749–754.

Paulsen, J. S., Ready, R. E., Hamilton, J. M., Mega, M. S., & Cummings, J. L. (2001). Neuropsychiatric aspects of Huntington’s disease. Journal of Neurology, Neurosurgery & Psychiatry, 71(3), 310–314.

Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Ricardo Osorio | Clinical Neuroscience | Best Researcher Award

Dr. Ricardo S. Osorio is a tenured Associate Professor of Psychiatry and Radiology at NYU Grossman School of Medicine, where he directs the Healthy Brain Aging and Sleep Center and serves as Director of the Biomarker Core within the NYU Alzheimer’s Disease Research Center. A physician-scientist, Dr. Osorio investigates the interplay of sleep, vascular, and inflammatory mechanisms in Alzheimer’s disease, integrating multimodal biomarkers, neuroimaging, and detailed clinical phenotyping. He has led several landmark studies, including trials on sleep apnea, amyloid and tau accumulation, brain energetics, and locus coeruleus dysfunction, exploring how sleep and metabolic factors influence cognitive decline and neurodegeneration. His work has significantly advanced translational biomarker development, assay harmonization, and inclusive recruitment in aging research. Dr. Osorio has published over 130 peer-reviewed articles in top journals such as JAMA Neurology, Annals of Neurology, Sleep, Alzheimer’s & Dementia, Lancet, and Brain, contributing to more than 8,369 citing documents, with a total citation count of 9,893 and an h-index of 44. He serves on multiple editorial boards, including Sleep Medicine Reports, and has provided expert peer review for leading journals worldwide. His collaborative network spans the NYU Alzheimer’s Disease Research Center, Mount Sinai, the ENIGMA-Sleep Consortium, and numerous national and international aging and sleep research initiatives, mentoring the next generation of clinician-scientists while shaping the field of sleep and neurodegeneration.

Profiles: Scopus | Orcid | Google Scholar

Featured Publications

  1. Author(s). (Year). Disordered sleep and painful diabetic neuropathy (PDN): A review of the literature on pathophysiology, pharmacologic and nonpharmacologic treatment options, and future directions. Journal Name, Volume(Issue), pages.

  2. Author(s). (2025). EEG slow oscillations and overnight spatial navigational memory performance in CPAP-treated obstructive sleep apnea. Sleep, Volume(Issue), pages.

  3. Author(s). (2025). High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer’s disease dementia. Alzheimer’s & Dementia, Volume(Issue), pages.

  4. Author(s). (2025). Impact of Alzheimer’s disease on sleep in adults with Down syndrome. Alzheimer’s & Dementia, Volume(Issue), pages.

  5. Author(s). (2025). Sleep-wake variation in body temperature regulates tau secretion and correlates with CSF and plasma tau. Journal of Clinical Investigation, Volume(Issue), pages.

  6. Author(s). (2025). The stability of slow-wave sleep and EEG oscillations across two consecutive nights of laboratory polysomnography in cognitively normal older adults. Journal of Sleep Research, Volume(Issue), pages.

  7. Author(s). (2025). Two-year longitudinal outcomes of subjective cognitive decline in Hispanics compared to non-Hispanic Whites. Journal of Geriatric Psychiatry and Neurology, Volume(Issue), pages.

  8. Author(s). (Year). Enhancing sleep, wakefulness, and cognition with transcranial photobiomodulation: A systematic review. Journal Name, Volume(Issue), pages.

  9. Author(s). (2024). The relationship between anxiety and levels of Alzheimer’s disease plasma biomarkers. Journal of Alzheimer’s Disease, Volume(Issue), pages.

  10. Author(s). (2024). The neutrophil to lymphocyte ratio associates with markers of Alzheimer’s disease pathology in cognitively unimpaired elderly people. Immunity and Ageing, Volume(Issue), pages.

Irene Litvan | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Irene Litvan | Clinical Neuroscience | Best Researcher Award

Dr. Irene Litvan | University of California San Diego | United States

Dr. Irene Litvan, MD, is the Tasch Endowed Professor of Neurology and Director of the Parkinson and Other Movement Disorders Center at the University of California, San Diego. She is internationally recognized for her pioneering work in movement disorders, particularly Parkinson’s disease and related neurodegenerative conditions. As a leading clinician-scientist, she has directed major multicenter and international initiatives to develop clinical and neuropathologic diagnostic criteria, identify disease biomarkers, and advance therapeutic interventions. Her extensive research spans epidemiologic, genetic, and clinico-pathologic correlation studies that have significantly deepened the understanding of movement disorders. Dr. Litvan’s scholarly impact is reflected in 6 published documents, 10 citations, and an h-index of 1. Throughout her distinguished career, she has received consistent funding support from national and international agencies, industry collaborations, and philanthropic organizations. Beyond her research, she has served as a dedicated mentor, shaping the next generation of neurologists and neuroscientists. Dr. Litvan also leads the UC San Diego Parkinson and Other Movement Disorders Center, fostering clinical excellence and research innovation aimed at improving diagnosis, management, and quality of life for individuals with Parkinson’s disease and other movement-related neurological disorders.

Featured Publications

Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., et al. (2015). MDS clinical diagnostic criteria for Parkinson’s disease. Movement Disorders, 30(12), 1591–1601.

McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O’Brien, J. T., Feldman, H., et al. (2005). Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology, 65(12), 1863–1872.

Dubois, B., Slachevsky, A., Litvan, I., & Pillon, B. (2000). The FAB: A frontal assessment battery at bedside. Neurology, 55(11), 1621–1626.

Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Movement Disorders, 22(12), 1689–1707.

Litvan, I., Goldman, J. G., Tröster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: Movement Disorder Society Task Force guidelines. Movement Disorders, 27(3), 349–356.

Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS–SPSP international workshop. Neurology, 47(1), 1–9.

Höglinger, G. U., Respondek, G., Stamelou, M., Kurz, C., Josephs, K. A., Lang, A. E., et al. (2017). Clinical diagnosis of progressive supranuclear palsy: The Movement Disorder Society criteria. Movement Disorders, 32(6), 853–864.

Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mrs. Claudia Pauciulo | Clinical Neuroscience | Best Researcher Award

Mrs. Claudia Pauciulo | Borghesiana Veterinary Clinic | Italy

Mrs. Claudia Pauciulo is the Head of the Neurology and Neurosurgery Department at Borghesiana Veterinary Clinic in Rome, Italy, and a certified veterinary neurologist completing her ECVN Residency. She holds a Master’s Degree in Diagnostic Imaging and a GP Certificate in Neurology, combining strong academic training with extensive clinical experience in advanced diagnostics (MRI, CT), neurosurgery, and case management. Her research focuses on feline and canine hyperesthesia syndromes, central nervous system lymphoma, intervertebral disc disease, and peripheral neuropathies. Dr. Pauciulo has published as both first author and coauthor in high-impact, peer-reviewed journals, including the Journal of Veterinary Internal Medicine, Journal of the American Veterinary Medical Association, Veterinary Record Case Reports, Journal of Small Animal Practice, and Veterinary Sciences (MDPI). She maintains an active citation record with growing visibility in Scopus- and SCI-indexed publications. Her current h-index is 2, with a total of 10 citations across multiple publications. Through her collaborative research with leading ECVN diplomates and contributions to international neurology congresses, Dr. Pauciulo continues to advance veterinary neuroscience, integrating clinical excellence with innovative research to improve evidence-based therapeutic strategies for neurological disorders in companion animals.

Profiles: Orcid | Linked In

Featured Publication

Pauciulo, C., & Gallucci, A. (2025, September 25). Long‐term outcome of presumptive idiopathic hyperesthesia syndrome in a dog treated with fluoxetine. Veterinary Record Case Reports.

Stanley Zimba | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Stanley Zimba | Clinical Neuroscience | Best Researcher Award

Dr. Stanley Zimba | University of Zambia School of Medicine | Zambia

Stanley Zimba is a distinguished neurologist and academic whose career reflects a rare blend of clinical excellence, research innovation, and medical leadership. With a strong educational foundation in medicine and advanced training in neurology, he has dedicated himself to improving neurological care and education in Zambia. His professional endeavors span across clinical practice in leading hospitals, teaching roles at multiple universities, and leadership in professional organizations. His research has focused on neuroHIV, neuromuscular disorders, and epilepsy, often conducted in collaboration with globally recognized institutions. His outstanding work has earned him prestigious international fellowships, awards, and recognition, making him a prominent voice in neurology within sub-Saharan Africa.

Profile

Orcid

Early Academic Pursuits

Stanley Zimba began his academic journey with a strong foundation in the sciences, excelling early in his studies and securing recognition as one of the most outstanding students of his time. His pursuit of higher education led him to the University of Zambia, where he undertook rigorous training in medicine. He first completed a degree in Human Biology before advancing to obtain his Bachelor of Medicine and Bachelor of Surgery. His intellectual curiosity and commitment to medical excellence propelled him to further specialization with a Master of Medicine in Internal Medicine. Driven by a passion for advancing neurological sciences, he embarked on advanced fellowship training in Adult Neurology and later pursued doctoral research in Adult Neurology at the University of Zambia, building the foundation for his career as a clinician–scientist.

Professional Endeavors

Zimba’s professional career has been deeply rooted in both clinical practice and academic medicine. As a consultant neurologist, he has played a central role in establishing neurology services within Zambia’s leading medical institutions, including the University Teaching Hospital where he leads the Neurology and Hematology Unit. His expertise has been sought by private hospitals, where he contributes to expanding access to specialized neurological care. Beyond hospital practice, his influence extends into academia, where he serves as an honorary lecturer across several medical universities in Zambia, shaping the next generation of physicians. His leadership extends further into professional organizations, where he has assumed prominent roles that guide the direction of neurological practice and training within the country.

Contributions and Research Focus

At the heart of Zimba’s career lies a dedication to advancing knowledge in neurology, with particular attention to neurological complications of infectious diseases, neuroHIV, neuromuscular disorders, and epilepsy. His research activities have been strengthened through international collaborations with institutions such as Johns Hopkins University, Harvard University, and the University of Cape Town. He has engaged in translational research exploring the interface between infectious diseases and neurological health, addressing critical gaps in understanding how conditions such as HIV contribute to neurological morbidity. His academic work reflects a blend of clinical expertise and research innovation, positioning him as a leading figure in developing evidence-based approaches to neurological care in sub-Saharan Africa.

Accolades and Recognition

Zimba’s academic and professional journey has been marked by significant recognition from both local and international institutions. He has received prestigious scholarships and fellowships from globally renowned organizations, including the American Academy of Neurology, the Fogarty International Center, and the Peripheral Nerve Society. His contributions have also been acknowledged through competitive awards for scholarly excellence, such as recognition for best scientific presentations and leadership fellowships in global health research. These honors reflect not only his personal commitment to academic excellence but also the international value of his work in neurology.

Impact and Influence

Through his roles in clinical practice, teaching, and leadership, Zimba has had a profound impact on the development of neurology in Zambia. As head of neurology services in the nation’s largest teaching hospital, he has shaped clinical protocols and advanced the training of physicians in specialized neurological care. His academic mentorship has inspired many young medical professionals to pursue careers in neurology and internal medicine. His leadership in professional associations has also created platforms for collaboration, advocacy, and policy development, ensuring that neurological health remains a priority in national and regional health agendas.

Legacy in Medical Leadership

Zimba’s leadership extends beyond the clinic and classroom into national medical governance. By directing specialist training programs and contributing to the regulation of internal medicine through the Health Professions Council of Zambia, he has influenced the standards of medical education and practice across the country. His presidency of the Neurological Association of Zambia positions him as a central figure in shaping the future of neurological practice, advocacy, and awareness, ensuring that patients with neurological disorders receive improved recognition and care.

Future Contributions

Looking forward, Zimba is poised to leave a lasting legacy through his continued commitment to advancing neurological sciences in Zambia and the wider region. His doctoral research and international collaborations promise to generate new insights into neurological disease management, while his leadership roles will likely foster stronger systems for specialist training and healthcare delivery. By combining clinical expertise, academic mentorship, and institutional leadership, he is set to play an instrumental role in positioning Zambia as a center of excellence for neurology in Africa. His career trajectory illustrates a deep dedication not only to scientific advancement but also to the betterment of patient care and health systems in resource-limited settings.

Publications

The Association of Premature Atherosclerosis with Ischemic Stroke in Young People with HIV in Lusaka, Zambia
Authors: Stanley Zimba; Owen Ngalamika; Emmanuel Mukambo; Theresa Shankanga; Bwalya Mulenga; Mike Chisha; Violet Kayamba; Lloyd Mulenga; Omar Siddiqi; Owen A. Ross et al.
Year: 2025

Clinical Reasoning: Rapidly Progressive Dementia in a Man With HIV Infection and Undetectable Plasma Viral Load
Authors: Lorraine Chishimba Chishimba; Mashina Chomba; Stanley Zimba; Melody Tunsubilege Asukile; Obrie Makai; Deanna R. Saylor
Year: 2023

The case of a 42‐year‐old man with progressive gait instability, dysarthria, and dysphagia
Authors: Jennifer Adrissi; Mashina Chomba; Lorraine Chishimba; Stanley Zimba; Igor J. Koralnik; Deanna Saylor
Year: 2023

A Notable Prevalence of HIV-Associated Stroke in an Endemic Region
Authors: Stanley Zimba; Laura Benjamin
Year: 2022

Implementation of a Teleneurology Clinic in Zambia during the COVID‐19 Pandemic
Authors: Melody Asukile; Lorraine Chishimba; Mashina Chomba; Moses Mataa; Frighton Mutete; Naluca Mwendaweli; Kunda Yumbe; Stanley Zimba; Gloria Habanyama; Sydney Shampile et al.
Year: 2022

Inpatient Management of Acute Stroke of Unknown Type in Resource-Limited Settings
Authors: Morgan L. Prust; Deanna Saylor; Stanley Zimba; Fred Stephen Sarfo; Gentle S. Shrestha; Aaron Berkowitz; Nirali Vora
Year: 2022

Clinical Reasoning: An Unusual Case of Acute Psychosis and Tetraparesis in a Young Zambian Man
Authors: Stanley Zimba; Lorraine Chishimba; Mashina Chomba; Deanna Saylor
Year: 2021

Immune reconstitution inflammatory syndrome: a report of TB-IRIS after switching from efavirenz to dolutegravir
Authors: Stanley Zimba; Nyuma Mbewe; Lorraine Chishimba; Mashina Chomba; Deanna Saylor
Year: 2021

Conclusion

Dr. Zimba’s contributions exemplify the qualities of a transformative clinician–scientist who bridges research, practice, and leadership. His work has significantly advanced the understanding and treatment of neurological disorders in Zambia, while also elevating medical education and training standards. Through his leadership positions, he has shaped healthcare policy, specialist training, and advocacy for neurological health. Looking to the future, his research and leadership promise to strengthen neurology as a field in Africa, leaving a legacy of scientific advancement, patient-centered care, and mentorship for future generations.

Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Antonella Santuccione Chadha | Clinical Neuroscience | Best Researcher Award

Dr. Antonella Santuccione Chadha, Women` s Brain Foundation,  Switzerland.

Dr. Antonella Chadha Santuccione is a highly accomplished clinical pathologist, neuroscientist, and executive leader with notable expertise in clinical trial management and cognitive behavioral therapy. Born in Italy and based in Switzerland, she has held executive roles and board memberships across biotech and healthcare organizations. She is also the founder and pro-bono CEO of the Women’s Brain Foundation, emphasizing her commitment to neuroscience and gender-specific brain health.

Profile

Scopus
Orcid

📚 Early Academic Pursuits

Dr. Antonella Chadha Santuccione’s academic foundation is deeply rooted in medical science and behavioral therapy, reflecting her passion for understanding the human mind and body. Born on June 13, 1974, in Penne, Italy, she pursued her education in medicine, earning her MD with specialization in Clinical Pathology. Furthering her academic rigor, she attained credentials from FMH and MEBEKO and completed a CAS in Clinical Trial Management. With an eye toward holistic care and human psychology, she expanded her studies to include Cognitive Behavioral Therapy. Her diverse training laid the groundwork for a multifaceted approach to clinical neuroscience, bridging biology, diagnostics, and therapeutic psychology.

🧪 Professional Endeavors

Throughout her professional journey, Dr. Santuccione has combined her clinical acumen with entrepreneurial vision. After relocating to Switzerland, she took on advisory roles in several neuro-focused start-ups including Bottneuro, Altoida, Pipra, ReconnectLab, and EqualCare, where she played a pivotal role in aligning scientific discovery with patient-centered innovation. Serving as an Executive Director and Board Member across multiple initiatives, she brought together cross-disciplinary teams to push the frontiers of diagnostics and digital health. Her pro-bono leadership as the Founder and CEO of the Women’s Brain Foundation further demonstrates her commitment to addressing gender disparities in brain health research and care.

🧠 Contributions and Research Focus

Dr. Santuccione’s work focuses on the intersection of neuroscience, gender-specific medicine, and clinical innovation. Her research advocacy highlights the importance of considering sex differences in neurodegenerative diseases such as Alzheimer’s, a field historically underexplored. By promoting personalized approaches to brain health, she has helped shape how researchers and clinicians think about prevention, diagnosis, and treatment across genders. Her insights into cognitive decline, early diagnostic markers, and patient-centric treatment frameworks have influenced both academic thought and clinical practice. Additionally, her work in start-ups integrates AI and data-driven technologies to monitor cognitive health, marking her as a forerunner in digital neuroscience.

🏅 Accolades and Recognition

Dr. Santuccione’s contributions have earned her widespread acclaim both within Switzerland and internationally. She was selected among the Top 100 Business Women in Switzerland from 2018 to 2023, a testament to her sustained influence in science and innovation. In 2019, she was named Woman of the Year by Women in Business CH through a public election, highlighting her societal impact beyond the scientific community. The World Sustainability Award in 2020 and the Bold Women Award Switzerland in 2022 recognized her efforts in building ethical, inclusive scientific models. Most recently, she received the Empowering Women Award 2024 and was featured among the Women to Watch 2025, celebrating her as a role model for future leaders.

🌍 Impact and Influence

Beyond her clinical and scientific achievements, Dr. Santuccione has become a global advocate for change in the healthcare landscape. Her work challenges the traditional silos of medicine, psychology, and technology, offering integrative solutions that are ethical and inclusive. She has empowered countless women in STEM through her foundation, speaking engagements, and mentorship programs. Her influence extends into public policy discussions and public health awareness campaigns, where she brings attention to the need for gender equity and individualized treatment in brain disorders. She is not only a scientist but a communicator who bridges science and society.

💡 Legacy and Future Contributions

Dr. Antonella Chadha Santuccione is a trailblazer shaping the next era of neuroscience through compassion-driven research and visionary leadership. Her legacy lies in her determination to dismantle systemic barriers in medicine—especially those that affect women—and in creating frameworks where innovation serves the individual. With ongoing roles in biotech leadership, nonprofit work, and public advocacy, she is set to further influence global conversations around brain health, mental wellness, and gendered research. Her career is a beacon for aspiring researchers who believe that science should serve humanity with empathy, precision, and equity.

🧬 A Champion for Brain Science and Humanity

Dr. Santuccione embodies the rare synthesis of scientific brilliance, leadership excellence, and humanitarian vision. Her work underscores a commitment to better understanding the human brain—not only through the lens of pathology, but also through the lens of experience, gender, and empathy. As she continues her journey, she stands as a symbol of what it means to be a 21st-century neuroscientist: grounded in evidence, driven by innovation, and devoted to people.

Publication

1. Title: Women’s brain health and brain capital
Authors: Laura Castro-Aldrete, Megan Greenfield, Erin Smith, Harris A. Eyre, Mariapaola Barbato, Lucy Pérez, Antonella Santuccione Chadha
Year: 2025

2. Title: Abortion and Miscarriage on Twitter: Sentiment and Polarity Analysis from a gendered perspective
Authors: Olivier Philippe, María Flores Rodero, Claire Yohalem Furtick, Laura Planas Simón, Maria Teresa Ferretti, Antonella Santuccione Chadha, Laia Subirats Maté, Davide Cirillo, María José Rementeria
Year: 2024

3. Title: Inducing prion protein shedding as a neuroprotective and regenerative approach in pathological conditions of the brain: from theory to facts
Authors: Matamoros-Angles A, Mohammadi B, Song F, Shafiq M, Brenna S, Puig B, Glatzel M, Altmeppen HC
Year: 2023

4. Title: Global synergistic actions to improve brain health for human development
Authors: Owolabi MO, Leonardi M, Bassetti C, Jaarsma J, Hawrot T, Makanjuola AI, Dhamija RK, Feng W, Straub V, Camaradou J, et al.
Year: 2023

5. Title: Sex and gender considerations in Alzheimer’s disease: The Women’s Brain Project contribution
Authors: Laura Castro-Aldrete, Moser MV, Putignano G, Ferretti MT, Schumacher Dimech A, Antonella Santuccione Chadha
Year: 2023

6. Title: Towards AI-driven longevity research: An overview
Authors: Marino N, Putignano G, Cappilli S, Chersoni E, Antonella Santuccione Chadha, Calabrese G, Bischof E, Vanhaelen Q, Zhavoronkov A, Scarano B
Year: 2023

7. Title: Amyloid precursor protein (APP) and amyloid β (Aβ) interact with cell adhesion molecules: Implications in Alzheimer’s disease and normal physiology
Authors: Pfundstein G, Nikonenko AG, Sytnyk V
Year: 2022

8. Title: Prions induce an early Arc response and a subsequent reduction in mGluR5 in the hippocampus
Authors: Ojeda-Juárez D, Lawrence JA, Soldau K, Pizzo DP, Wheeler E, Aguilar-Calvo P, Khuu H, Chen J, Malik A, Funk G, et al.
Year: 2022

9. Title: Digital biomarkers and sex impacts in Alzheimer’s disease management – potential utility for innovative 3P medicine approach
Authors: Harms RL, Ferrari A, Meier IB, Martinkova J, Santus E, Marino N, Cirillo D, Mellino S, Catuara Solarz S, Tarnanas I, et al.
Year: 2022

🏁 Conclusion

Dr. Antonella Chadha Santuccione’s career is a model of interdisciplinary excellence, innovation, and advocacy. Her ability to blend neuroscience research with executive leadership and public engagement sets her apart as a visionary in brain health. She not only advances the scientific understanding of neurodegeneration but also actively reshapes how gender and equity are addressed in medical research. With a lasting legacy in both scientific and humanitarian domains, she is exceptionally well-suited for high-level recognition such as the Best Researcher Award and remains a powerful voice shaping the future of neuroscience globally.